Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Therapy in Refractory Crohn's Disease
NCT01540292Phase 2Terminated
- Sponsor
- University of Liège
- Start
- Feb 2013
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in Crohn's disease, sponsored by University of Liège. Started Feb 2013; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01540292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540292.